In the last decade, the number of measles cases in Europe has surged alarmingly. According to the World Health Organization (WHO), cases increased from a historical low of 132,490 in 2016<\/strong> to a staggering 869,770 in 2019<\/strong>, and estimates suggest it exceeded 10 million in 2023<\/strong>. This upward trend is largely attributed to lack of vaccination<\/strong>, either due to hesitancy or accessibility issues, marking a pivotal moment for public health.<\/p>\n Spain has witnessed a less dramatic rise, but it is not immune to this resurgence. \u00c1ngela Dom\u00ednguez, coordinator of the Vaccines Working Group of the Spanish Society of Epidemiology (SEE), notes that this rise hasn\u2019t been linear, especially after the pause caused by the COVID-19 pandemic. Fernando Moraga-Llop from the Spanish Association of Vaccinology (AEV) highlights that Spain experienced a substantial increase in infections over the past three years\u2014rising from 14 cases in 2023<\/strong> to 395 in the previous year<\/strong>.<\/p>\n Spain held the title of being measles-free<\/strong> since 2017, awarded by the WHO’s European Regional Verification Committee. From 2014 to 2016<\/strong>, there were no indigenous cases, placing Spain in a favorable position compared to countries like France, Germany, and Italy. However, recent WHO reports indicate the potential emergence of a transmission chain lasting over 12 months<\/strong>, as echoed by health officials.<\/p>\n Despite prior warnings from healthcare professionals about rising cases and the deteriorating importance given to the issue, public trust in vaccines has significantly weakened. Ignacio Domingo, coordinator of the Vaccines Group of the Spanish Association of Pediatric Primary Care (AEPap), attributes this decline to coverage rates that are not as robust as they should be<\/strong>. Individuals who are either unvaccinated or only receive one dose are particularly vulnerable, with the potential to transmit the highly contagious virus to others.<\/p>\n To control measles, vaccination coverage must surpass 95% for both doses<\/strong>. However, current data shows a concerning decline: the first dose decreased from 97.8%<\/strong> to 97%<\/strong> between 2024 and 2025<\/strong>, while the second dose dropped from 94.4%<\/strong> to 91%<\/strong>.<\/p>\n Coverage rates vary significantly across Spain. While 12 autonomous regions<\/strong> meet or exceed the 95% target for the first dose, others fall alarmingly short. For instance, Melilla<\/strong> records a figure below 90%. The second dose also needs urgent attention, with regions like Castilla-La Mancha<\/strong> and Basque Country<\/strong> reporting rates below 90%, placing them at high risk of outbreaks.<\/p>\n In addition to improving vaccination rates, enhanced surveillance is critical<\/strong>. Effective tracking and traceability of infections are paramount. As Maria del Mar Tom\u00e1s from the Spanish Society of Infectious Diseases and Clinical Microbiology emphasizes, early identification of suspected cases<\/strong> through rapid molecular diagnosis can help in effective management and containment.<\/p>\n By 2025<\/strong>, worrying trends show that 48%<\/strong> of recorded cases lacked known origins, making it challenging to ascertain whether these were imported or local infections. Many recent cases stem from countries with lower vaccination rates, such as Morocco<\/strong> and Romania<\/strong>.<\/p>\n Experts agree that recovering the measles-free status<\/strong> hinges on attaining vaccination coverages above 95%<\/strong> and rigorous health monitoring. Although the path to reversing the current scenario may take two to three years<\/strong>, the consensus is that it is feasible. <\/p>\n Healthcare professionals stress that the first vaccination dose<\/strong> tends to be administered without issue; however, the second dose faces significant hesitation. Active recapture strategies to monitor vaccination schedules during any healthcare interaction are vital to ensuring children remain adequately protected.<\/p>\n To combat the rise in measles cases, it\u2019s essential for Spain to strengthen its vaccination strategies, close regional gaps, and maintain a proactive approach to health surveillance. The message is clear: No case should go unnoticed, as continuous monitoring and vaccination are pivotal in averting future outbreaks of this preventable disease.<\/p>\nDecline from Safe Status<\/h4>\n
The Shortcomings in Spain’s Vaccine Coverage<\/h4>\n
Regional Disparities in Vaccination Rates<\/h4>\n
The Need for Enhanced Surveillance<\/h4>\n
Steps to Regain Measles-Free Status<\/h4>\n
Conclusion<\/h4>\n